Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas–Implications for tumor biology and potential clinical utility
- 16 August 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (36) , 5033-5042
- https://doi.org/10.1038/sj.onc.1204613
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 30 references indexed in Scilit:
- Maternal immunity against rabies in raccoon dogsActa Veterinaria Hungarica, 2001
- Evidence that haploinsufficiency ofPtch leads to medulloblastoma in miceGenes, Chromosomes and Cancer, 2000
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- Analysis of the max-binding protein MNT in human medulloblastomasInternational Journal of Cancer, 1999
- Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic diseaseEuropean Journal of Human Genetics, 1999
- A New Tool for the Rapid Cloning of Amplified and Hypermethylated Human DNA Sequences from Restriction Landmark Genome Scanning GelsGenomics, 1999
- High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11.2Genes, Chromosomes and Cancer, 1997
- Medulloblastoma: is the 5-year survival rate improving?Journal of Neurosurgery, 1997
- Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.Proceedings of the National Academy of Sciences, 1994
- The Lack of a Role for p53 in Astrocytomas in Pediatric PatientsNeurosurgery, 1994